Tag: Therapy & Procedures: Misc.
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
Convalescent Plasma Has Limited Benefit for Moderate COVID-19
Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
Pharmacotherapy, Psychotherapy Combo Best for Bipolar Disorder
Manualized treatments linked to significantly reduced recurrence rates versus control treatments
Outcomes Worse for Women With MI at 50 Years or Younger
Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment
ACS: Tranexamic Acid No Better Than Placebo After Severe Injury
Antifibrinolytic agent may lower 30-day mortality when used within one hour of injury, for severe shock
Glecaprevir and Pibrentasvir Aid HCV D+/R− Kidney Transplants
Two studies demonstrate safe transplant of kidneys from deceased donors with HCV infection
Lack of Knowledge Barrier to Prone Positioning Use in ARDS
Implementation strategies developed included educational outreach, learning collaborative
More Than Half of Cancer Patients Willing to Enroll in Clinical Trials
Participation rates similar for Black and White patients, treatment and cancer control trials
Remote Ischemic Postconditioning May Aid Stroke Recovery
More patients with acute ischemic stroke in RIPC group had excellent recovery at three months
Fecal Transplant Safe, Effective for C. Difficile Through Six Months
90 percent of those undergoing FMT had one-month cure; 4 percent had recurrence within six months
